Discovery Genomics Inc.
http://www.discoverygenomics.net
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Discovery Genomics Inc.
Deals Shaping the Medical Industry, April 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in March 2016.
Start-Up Previews (2/05)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Convergence: What's Next at the Nexus?, features profiles of Direct-Haler, EndoBionics, Polymerix and X-Cell Medical. Plus these Start-Ups across Health Care: Discovery Genomics, FoldRx and Neuronetics.
Discovery Genomics Inc.
Discovery Genomics Inc.'s Sleeping Beauty transposon vector is non-viral, but it can integrate into the genome to achieve long-term expression. DGI uses it in two parts: the transposon vector carries the therapeutic genes, and the transposase enzyme moves it from the vector into the chromosome. When delivered to cells at the same time, the transposase cuts the therapeutic gene out of the vector and inserts it into the host chromosome, much like you cut and paste using a word processor.
Recent Dealmaking (10/2002)
Summarizing the month in European dealmaking.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice